Weight Management
Next-generation GLP-1 and multi-receptor agonist peptides for clinical weight management.
Retatrutide
Triple agonist peptide targeting GIP, GLP-1, and glucagon receptors. Lyophilised powder for reconstitution in clinical weight management protocols.
Retatrutide
Retatrutide 10mg lyophilised powder for clinical weight management applications.
Retatrutide
Retatrutide 20mg lyophilised powder for clinical weight management applications.
Retatrutide
Retatrutide 30mg lyophilised powder for advanced clinical weight management protocols.
Retatrutide
Maximum-dosage Retatrutide lyophilised powder for intensive clinical weight management protocols.
Tirzepatide
Dual GIP/GLP-1 receptor agonist peptide in lyophilised powder form. For reconstitution in clinical weight management and metabolic health protocols.
Tirzepatide
Tirzepatide 10mg lyophilised powder for clinical applications.
Tirzepatide
Tirzepatide 20mg lyophilised powder for clinical applications.
Tirzepatide
Tirzepatide 30mg lyophilised powder for clinical applications.
Tirzepatide
Tirzepatide 40mg lyophilised powder for advanced clinical protocols.
Tirzepatide
Maximum-dosage Tirzepatide lyophilised powder for intensive clinical protocols.
Semaglutide
GLP-1 receptor agonist with an extended half-life achieved through albumin binding via a C-18 fatty acid chain. The most widely prescribed incretin-ba...
Liraglutide
GLP-1 receptor agonist with 97% homology to native human GLP-1. Acylated with a C-16 fatty acid for albumin binding and extended duration of action.
Dulaglutide
GLP-1 receptor agonist fused to a modified IgG4 Fc fragment for extended pharmacokinetics. Designed for once-weekly administration in metabolic health...
Cagrilintide
Long-acting amylin analogue designed for once-weekly subcutaneous administration. Activates amylin receptors to reduce appetite and slow gastric empty...
CagriSema
Fixed-ratio combination of cagrilintide (amylin analogue) and semaglutide (GLP-1 agonist). Dual incretin pathway activation for enhanced weight manage...
Survodutide
Dual GLP-1 and glucagon receptor agonist designed for weight management and metabolic health. Glucagon receptor activation enhances energy expenditure...
AOD-9604
Modified fragment (176-191) of human growth hormone with a tyrosine residue at position 177. Retains the lipolytic activity of HGH without growth-prom...
HGH Fragment 176-191
C-terminal fragment of human growth hormone encompassing amino acids 176-191. Specifically targets adipose tissue for fat metabolism without anabolic ...
5-Amino-1MQ
Small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Blocks NNMT activity to increase NAD+ levels in adipose tissue and enhance cellul...
Adipotide (FTPP)
Peptidomimetic that targets prohibitin on the surface of blood vessels supplying white adipose tissue. Induces apoptosis of endothelial cells feeding ...
For professional medical use only. This product is not intended for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.